Internal Medicine, Pulmonary Disease · Houston, TX
NPI
1215989900
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
13219 Dotson Rd Ste 210
Houston, TX, 77070
Phone (281) 955-0338
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
58,231 services
Medicare patients, 2024
909
Average age 74
Drug cost, 2024
$2.7M
6,423 prescriptions
Company payments, 2025
$5,738
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dileep K Puppala was code J2356 (injection, tezepelumab-ekko, 1 mg), 38,220 times for 26 patients. In total Dileep K Puppala billed 58,231 services in 45 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 38,220 | 26 | $14.21 | $543K |
| J2182 Injection, mepolizumab, 1 mg | Office | 12,700 | 19 | $23.79 | $302K |
| 99214 Office E&M - Established | Office | 1,457 | 638 | $85.34 | $124K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 800 | 28 | $0.23 | $185 |
| 96401 Chemotherapy Administration | Office | 455 | 52 | $50.21 | $23K |
| 94010 Pulmonary Function Testing | Office | 371 | 331 | $18.55 | $6,884 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 276 | 35 | $45.54 | $13K |
| 99213 Office E&M - Established | Office | 192 | 164 | $59.67 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 155 | 52 | $79.07 | $12K |
| 94726 Pulmonary Function Testing | Office | 136 | 128 | $39.05 | $5,310 |
| 94729 Pulmonary Function Testing | Office | 126 | 119 | $39.23 | $4,942 |
| 99204 Office E&M - New | Office | 125 | 125 | $111.77 | $14K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 101 | 18 | $0.35 | $35.45 |
| 94060 Pulmonary Function Testing | Office | 82 | 79 | $27.88 | $2,286 |
| 96372 Injection Administration | Office | 79 | 42 | $10.37 | $819 |
By year: 2022 $681K for 20,525 services; 2023 $753K for 25,209 services; 2024 $1.2M for 58,231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dileep K Puppala prescribed most often to Medicare patients was Montelukast Sodium, with 1,083 prescriptions and refills. In total Dileep K Puppala wrote 6,423 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,083 | 2,390 | 322 | $9,529 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 719 | 801 | 279 | $17K |
| Prednisone Generic | 551 | 559 | 291 | $1,525 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 541 | 679 | 112 | $419K |
| Fluticasone Propionate Generic | 503 | 957 | 229 | $7,683 |
| Cefdinir Generic | 278 | 278 | 202 | $5,393 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 234 | 294 | 90 | $29K |
| Levocetirizine Dihydrochloride Generic | 213 | 389 | 66 | $2,144 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 168 | 211 | 60 | $14K |
| Azithromycin Generic | 149 | 170 | 111 | $1,730 |
| Doxycycline Hyclate Generic | 128 | 128 | 103 | $1,380 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 100 | 110 | 35 | $67K |
| Azelastine Hcl Generic | 98 | 191 | 44 | $2,186 |
| Symbicort Budesonide/Formoterol Fumarate | 93 | 137 | 28 | $32K |
| Breo Ellipta Fluticasone/Vilanterol | 90 | 121 | 25 | $46K |
Brand drugs: 2,036 claims; generic drugs: 4,387 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dileep K Puppala $5,738 ($5,738 in general payments such as food, travel and fees) from 28 companies. The largest payer was Inspire Medical Systems, Inc. with $1,720.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 13 | $1,720 |
| AstraZeneca Pharmaceuticals LP AZN | 28 | $795 |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $468 |
| GlaxoSmithKline, LLC. GSK | 27 | $423 |
| Insmed, Inc. INSM | 19 | $297 |
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $289 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $267 |
| Amgen Inc. AMGN | 8 | $252 |
| Genzyme Corporation SNY | 6 | $168 |
| Verona Pharma, Inc. VRNA | 7 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.